Snijders, Clara
,
Maihofer, Adam X.
Ratanatharathorn, Andrew
Baker, Dewleen G.
Boks, Marco P.
Geuze, Elbert
Jain, Sonia
Kessler, Ronald C.
Pishva, Ehsan
Risbrough, Victoria B.
Stein, Murray B.
Ursano, Robert J.
Vermetten, Eric
Vinkers, Christiaan H.
Smith, Alicia K.
Uddin, Monica
Rutten, Bart P. F.
Nievergelt, Caroline M. http://orcid.org/0000-0001-5766-8923
Funding for this research was provided by:
National Institute of Mental Health (R01MH106595, R01MH108826)
Article History
Received: 24 September 2019
Accepted: 19 December 2019
First Online: 13 January 2020
Ethics approval and consent to participate
: The MRS study was approved by the institutional review boards of the University of California San Diego, VA San Diego Research Service, and Naval Health Research Center. For Army STARRS, the study procedures were approved by the Institutional Review Boards of all collaborating organizations. The PRISMO study was approved by the ethical committee of the University Medical Center Utrecht, and was conducted in accordance with the Declaration of Helsinki. All subjects provided informed consent.
: Not applicable
: RCK received support for his epidemiological studies from Sanofi Aventis; was a consultant for Johnson & Johnson Wellness and Prevention, Sage Pharmaceuticals, Shire, Takeda; and served on an advisory board for the Johnson & Johnson Services Inc. Lake Nona Life Project. Kessler is a co-owner of DataStat, Inc., a market research firm that carries out healthcare research. MBS has in the past 3 years been a consultant for Actelion, Aptinyx, Bionomics, Dart Neuroscience, Healthcare Management Technologies, Janssen, Neurocrine Biosciences, Oxeia Biopharmaceuticals, Pfizer, and Resilience Therapeutics. The other authors declare that they have no competing interests.